Effects of glucocorticoids on fetal and neonatal lung development

Treatments in Respiratory Medicine

Volumn 3, Issue 5, 2004, Pages 295-306

  Grier, David G ^a,b   Halliday, Henry L ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b ROYAL MATERNITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ANTIOXIDANT; BETAMETHASONE; CATALASE; COPPER ZINC SUPEROXIDE DISMUTASE; DEXAMETHASONE; FATTY ACID SYNTHASE; GLUCOCORTICOID; GLUTATHIONE PEROXIDASE; LUNG SURFACTANT; MANGANESE SUPEROXIDE DISMUTASE; OXYGEN; RETINOIC ACID; SODIUM CHANNEL; SODIUM ION; SUPEROXIDE DISMUTASE; SURFACTANT PROTEIN A; SURFACTANT PROTEIN B; SURFACTANT PROTEIN C; SURFACTANT PROTEIN D; THYROID TRANSCRIPTION FACTOR 1; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2;

ABSORPTION; ANTIOXIDANT ACTIVITY; CLINICAL TRIAL; CORTICOSTEROID THERAPY; DRUG MECHANISM; ENZYME SYNTHESIS; FETUS; FETUS LUNG MATURATION; GENE EXPRESSION; HUMAN; LUNG ALVEOLUS; LUNG DEVELOPMENT; LUNG DYSPLASIA; LUNG FLUID; LUNG FUNCTION; LUNG STRUCTURE; META ANALYSIS; NEONATAL RESPIRATORY DISTRESS SYNDROME; NEWBORN; NONHUMAN; OXYGEN THERAPY; PERINATAL DEVELOPMENT; POSTNATAL CARE; PREMATURITY; PRENATAL CARE; PRIORITY JOURNAL; PROTEIN SYNTHESIS; REVIEW; SYSTEMATIC REVIEW;

BETAMETHASONE; FEMALE; FETAL ORGAN MATURITY; GLUCOCORTICOIDS; HUMANS; INFANT, NEWBORN; LUNG; PREGNANCY; RESPIRATORY DISTRESS SYNDROME, NEWBORN;

EID: 11044235058     PISSN: 11763450     EISSN: None     Source Type: Journal    
DOI: 10.2165/00151829-200403050-00004     Document Type: Review

References (120)

1. Liggins GC. Premature parturition after infusion of corticotrophin or cortisol into foetal lambs. J Endocrinol 1968 Oct; 42 (2): 323-9
2. Liggins GC, Howie RN. A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants. Pediatrics 1972 Oct; 50 (4): 515-25
3. Crowley P. Prophylactic corticosteroids for preterm birth (Cochrane Review). Available in The Cochrane Library [database on disk and CD ROM]. Updated quarterly. The Cochrane Collaboration; issue 1. Oxford: Update Software, 2003
4. Halliday HL. Costs and benefits of perinatal corticosteroid treatment. Prenat Neonatal Med 2000; 5: 201-3
5. Baden M, Bauer CR, Colle E, et al. A controlled trial of hydrocortisone therapy in infants with respiratory distress syndrome. Pediatrics 1972; 50: 526-34
6. Mammel MC, Green TP, Johnson DE, et al. Controlled trial of dexamethasone therapy in infants with bronchopulmonary dysplasia. Lancet 1983 Jun 18; 8338: 1356-8
7. Avery GB, Fletcher AB, Kaplan M, et al. Controlled trial of dexamethasone in respirator-dependent infants with bronchopulmonary dysplasia. Pediatrics 1985 Jan; 75 (1): 106-11
8. Halliday HL, Ehrenkranz RA, Doyle LW. Early postnatal (<96 hours) corticosteroids for preventing chronic lung disease in preterm infants (Cochrane Review). Available in The Cochrane Library [database on disk and CD ROM]. Updated quarterly. The Cochrane Collaboration; issue 1. Oxford: Update Software, 2003
9. Halliday HL, Ehrenkranz RA, Doyle LW. Moderately early (7-14 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants (Cochrane Review). Available in The Cochrane Library [database on disk and CD ROM]. Updated quarterly. The Cochrane Collaboration; issue 1. Oxford: Update Software, 2003
10. Halliday HL, Ehrenkranz RA, Doyle LW. Delayed (>3 weeks) postnatal corticosteroids for chronic lung disease in preterm infants (Cochrane Review). Available in The Cochrane Library [database on disk and CD ROM]. Updated quarterly. The Cochrane Collaboration; issue 1. Oxford: Update Software, 2003
11. Barnes PJ. Anti-inflammatory actions of glucocorticoids: molecular mechanisms. Clin Sci (Lond) 1998 Jun; 94 (6): 557-72
12. Vyas J, Kotecha S. Effects of antenatal and postnatal corticosteroids on the preterm lung. Arch Dis Child Fetal Neonatal Ed 1997 Sep; 77 (2): F147-50
13. Sullivan LC, Orgeig S. Dexamethasone and epinephrine stimulate surfactant secretion in type II cells of embryonic chickens. Am J Physiol Regul Integr Comp Physiol 2001 Sep; 281 (3): R770-7
14. Tan RC, Ikegami M, Jobe AH, et al. Developmental and glucocorticoid regulation of surfactant protein mRNAs in preterm lambs. Am J Physiol 1999 Dec; 277 (6 Pt 1): L1142-8
15. Ingbar DH, Duvick S, Savick SK, et al. Developmental changes of fetal rat lung Na-K-ATPase after maternal treatment with dexamethasone. Am J Physiol 1997 Apr; 272 (4 Pt 1): L665-72
16. Fardy CH, Silverman M. Antioxidants in neonatal lung disease. Arch Dis Child Fetal Neonatal Ed 1995 Sep; 73 (2): F112-7
17. Adcock IM. Glucocorticoid-regulated transcription factors. Pulm Pharmacol Ther 2001; 14 (3): 211-9
18. Kellendonk C, Tronche F, Reichardt HM, et al. Mutagenesis of the glucocorticoid. receptor in mice. J Steroid Biochem Mol Biol 1999 Apr-Jun; 69 (1-6): 253-9
19. Muller M, Renkawitz R. The glucocorticoid receptor. Biochim Biophys Acta 1991 Feb 16; 1088 (2): 171-82
20. Jantzen HM, Strahle U, Gloss B, et al. Cooperativity of glucocorticoid response elements located far upstream of the tyrosine aminotransferase gene. Cell 1987 Apr 10; 49 (1): 29-38
21. Ray A, Prefontaine KE, Ray P. Down-modulation of interleukin-6 gene expression by 17 beta-estradiol in the absence of high affinity DNA binding by the estrogen receptor. J Biol Chem 1994 Apr 29; 269 (17): 12940-6
22. Wolffe AP. Transcriptional control: sinful repression. Nature 1997 May 1; 387 (6628): 16-7
23. Newton R, Seybold J, Kuitert LM, et al. Repression of cyclooxygenase-2 and prostaglandin E2 release by dexamethasone occurs by transcriptional and post-transcriptional mechanisms involving loss of polyadenylated mRNA. J Biol Chem 1998 Nov 27; 273 (48): 32312-21
24. Jobe AH, Newnham J, Willet K, et al. Fetal versus maternal and gestational age effects of repetitive antenatal glucocorticoids. Pediatrics 1998 Nov; 102 (5): 1116-25
25. Watterbeig KL, Demers LM, Scott SM, et al. Chorioamnionitis and early lung inflammation in infants in whom bronchopulmonary dysplasia develops. Pediatrics 1996 Feb; 97 (2): 210-5
26. Bry K, Lappalainen U, Hallman M. Intraamniotic interleukin-1 accelerates surfactant protein synthesis in fetal rabbits and improves lung stability after premature birth. J Clin Invest 1997 Jun 15; 99 (12): 2992-9
27. Jobe AH, Ikegami M. Antenatal infection/inflammation and postnatal lung maturation and injury. Respir Res 2001; 2 (1): 27-32
28. Willet KE, Jobe AH, Ikegami M, et al. Antenatal endotoxin and glucocorticoid effects on lung morphometry in preterm lambs. Pediatr Res 2000 Dec; 48 (6):782-8
29. Hodson WA. Normal and abnormal structural development of the lung. In: Polin RA, Fox WW, editors. Fetal and neonatal physiology. Philadelphia (PA): WB Saunders Company, 1992: 771-83
30. DiFiore JW, Wilson JM. Lung development. Semin Pediatr Sing 1994; 3 (4): 221-32
31. Massaro D, Teich N, Maxwell S, et al. Postnatal development of alveoli: regulation and evidence for a critical period in rats. J Clin Invest 1985 Oct; 76 (4): 1297-305
32. Condon J, Gosden C, Gardener D, et al. Expression of type 21 1-beta-hydroxysteroid dehydrogenase and corticosteroid hormone receptors in early human fetal life. J Clin Endocrinol Metab 1998 Dec; 83 (12): 4490-7
33. Beer DG, Butley MS, Cunha GR, et al. Autoradiographic localization of specific [3H]dexamethasone binding in fetal lung. Dev Biol 1984 Oct; 105 (2): 351-64
34. Muglia LJ, Bae DS, Brown TT, et al. Proliferation and differentiation defects during lung development in corticotropin-releasing hormone-deficient mice. Am J Respir Cell Mol Biol 1999 Feb; 20 (2): 181-8
35. Tschanz SA, Damke BM, Burri PH. Influence of postnatally administered glucocorticoids on rat lung growth. Biol Neonat 1995; 68 (4): 229-45
36. Tschanz SA, Haenni B, Burri PH. Glucocorticoid induced impairment of lung structure assessed by digital image analysis. Eur J Pediatr 2002 Jan; 161 (1): 26-30
37. Adamson IY, King GM. Postnatal development of rat lung following retarded fetal lung growth. Pediatr Pulmonol 1988; 4 (4): 230-6
38. Okajima S, Matsuda T, Cho K, et al. Antenatal dexamethasone administration impairs normal postnatal lung growth in rats. Pediatr Res 2001 Jun; 49 (6): 777-81
39. Pillow JJ, Hall GL, Willet KE, et al. Effects of gestation and antenatal steroid on airway and tissue mechanics in newborn lambs. Am J Respir Crit Care Med 2001 Apr; 163 (5): 1158-63
40. Beck JC, Mitzner W, Johnson JW, et al. Betamethasone and the rhesus fetus: effect on lung morphometry and connective tissue. Pediatr Res 1981 Mar; 15 (3): 235-40
41. Bhatt AJ, Amin SB, Chess PR, et al. Expression of vascular endothelial growth factor and Flk-1 in developing and glucocorticoid-treated mouse lung. Pediatr Res 2000 May; 47 (5): 606-13
42. Quinn TP, Peters KG, De Vries C, et al. Fetal liver kinase 1 is a receptor for vascular endothelial growth factor and is selectively expressed in vascular endothelium. Proc Natl Acad Sci U S A 1993 Aug 15; 90 (16): 7533-7
43. Zeng X, Wert SE, Federici R, et al. VEGF enhances pulmonary vasculogenesis and disrupts lung morphogenesis in vivo. Dev Dyn 1998 Mar; 211 (3): 215-27
44. Ross SA, McCaffery PJ, Drager UC, et al. Retinoids in embryonal development. Physiol Rev 2000 Jul; 80 (3): 1021-54
45. Mangelsdorf DJ, Thummel C, Beato M, et al. The nuclear receptor superfamily: the second decade. Cell 1995 Dec 15; 83 (6): 835-9
46. Rush MG, Ul-Haq R, Chytil F. Opposing effects of retinoic acid and dexamethasone on cellular retinol-binding protein ribonucleic acid levels in the rat. Endocrinology 1991 Aug; 129 (2): 705-9
47. Massaro GD, Massaro D. Postnatal treatment with retinoic acid increases the number of pulmonary alveoli in rats. Am J Physiol 1996 Feb; 270 (2 Pt 1): L305-10
48. Massaro GD, Massaro D. Retinoic acid treatment partially rescues failed septation in rats and in mice. Am J Physiol Lung Cell Mol Physiol 2000 May; 278 (5): L955-60
49. Northway Jr WH, Rosan RC, Porter DY. Pulmonary disease following respirator therapy of hyaline-membrane disease: bronchopulmonary dysplasia. N Engl J Med 1967 Feb 16; 276 (7): 357-68
50. Jobe AJ. The new BPD: an arrest of lung development. Pediatr Res 1999 Dec; 46 (6): 641-3
51. Husain AN, Siddiqui NH, Stocker JT. Pathology of arrested acinar development in postsurfactant bronchopulmonary dysplasia. Hum Pathol 1998 Jul; 29 (7): 710-7
52. Coalson JJ, Winter VT, Siler-Khodr T, et al. Neonatal chronic lung disease in extremely immature baboons. Am J Respir Crit Care Med 1999 Oct; 160 (4): 1333-46
53. Albertine KH, Jones GP, Starcher BC, et al. Chronic lung injury in preterm lambs: disordered respiratory tract development. Am J Respir Crit Care Med 1999 Mar; 159 (3): 945-58
54. Coalson JJ, Winter VT, Gerstmann DR, et al. Pathophysiologic, morphometric, and biochemical studies of the premature baboon with bronchopulmonary dysplasia. Am Rev Respir Dis 1992 Apr; 145 (4 Pt 1): 872-81
55. Abman SH. Bronchopulmonary dysplasia: "a vascular hypothesis". Am J Respir Crit Care Med 2001 Nov 15; 164 (10 Pt 1): 1755-6
56. Watterberg KL, Gerdes JS, Cook KL. Impaired glucocorticoid synthesis in premature infants developing chronic lung disease. Pediatr Res 2001 Aug; 50 (2): 190-5
57. Wong YC, Beardsmore CS, Silverman M. Antenatal dexamethasone and subsequent lung growth. Arch Dis Child 1982 Jul; 57 (7): 536-8
58. Smolders-de Haas H, Neuvel J, Schmand B, et al. Physical development and medical history of children who were treated antenatally with corticosteroids to prevent respiratory distress syndrome: a 10- to 12-year follow-up. Pediatrics 1990 Jul; 86 (1): 65-70
59. Gluck L, Kulovich MV. Lecithin/spingomyelin ratios in amniotic fluid in normal and abnormal pregnancy. Am J Obstet Gynecol 1973 Feb 15; 115 (4): 539-46
60. Batenburg JJ. Surfactant phospholipids: synthesis and storage. Am J Physiol 1992 Apr; 262 (4 Pt 1): L367-85
61. Smith BT, Post M. Fibroblast-pneumonocyte factor. Am J Physiol 1989 Oct; 257 (4 Pt 1): L174-8
62. Rooney SA, Young SL, Mendelson CR. Molecular and cellular processing of lung surfactant. FASEB J 1994 Sep; 8 (12): 957-67
63. Wagle S, Bui A, Ballard PL, et al. Hormonal regulation and cellular localization of fatty acid synthase in human fetal lung. Am J Physiol 1999 Aug; 277 (2 Pt 1): L381-90
64. Xu ZX, Stenzel W, Sasic SM, et al. Glucocorticoid regulation of fatty acid synthase gene expression in fetal rat lung. Am J Physiol 1993 Aug; 265 (2 Pt 1): L140-7
65. Xu ZX, Viviano CJ, Rooney SA. Glucocorticoid stimulation of fatty-acid synthase gene transcription in fetal lung: antagonism by retinoic acid. Am J Physiol 1995 Apr; 268 (4 Pt 1): L683-90
66. Lu Z, Gu Y, Rooney SA. Transcriptional regulation of the lung fatty acid synthase gene by glucocorticoid, thyroid hormone and transforming growth factor-beta 1. Biochim Biophys Acta 2001 Jun 29; 1532 (3): 213-22
67. Rooney SA, Smart DA, Weinhold PA, et al. Dexamethasone increases the activity but not the amount of choline-phosphate cytidylyltransferase in fetal rat lung. Biochim Biophys Acta 1990 Jun 14; 1044 (3): 385-9
68. Ballard PL, Ning Y, Polk D, et al. Glucocorticoid regulation of surfactant components in immature lambs. Am J Physiol 1997 Nov; 273 (5 Pt 1): L1048-57
69. Ikegami M, Polk D, Jobe A. Minimum interval from fetal betamethasone treatment to postnatal lung responses in preterm lambs. Am J Obstet Gynecol 1996 May; 174 (5): 1408-13
70. Polk DH, Ikegami M, Jobe AH, et al. Postnatal lung function in preterm lambs: effects of a single exposure to betamethasone and thyroid hormones. Am J Obstet Gynecol 1995 Mar; 172 (3): 872-81
71. Kari MA, Akino T, Hallman M. Prenatal dexamethasone and exogenous surfactant therapy: surface activity and surfactant components in airway specimens. Pediatr Res 1995 Nov; 38 (5): 676-84
72. Mason RJ, Greene K, Voelker DR. Surfactant protein A and surfactant protein D in health and disease. Am J Physiol 1998 Jul; 275 (1 Pt 1): L1-13
73. Liley HG, White RT, Benson BJ, et al. Glucocorticoids both stimulate and inhibit production of pulmonary surfactant protein A in fetal human lung. Proc Natl Acad Sci U S A 1988 Dec; 85 (23): 9096-100
74. Odom MJ, Snyder JM, Boggaram V, et al. Glucocorticoid regulation of the major surfactant associated protein (SP-A) and its messenger ribonucleic acid and of morphological development of human fetal lung in vitro. Endocrinology 1988 Oct; 123 (4): 1712-20
75. Iannuzzi DM, Ertsey R, Ballard PL. Biphasic glucocorticoid regulation of pulmonary SP-A: characterization of inhibitory process. Am J Physiol 1993 Mar; 264 (3 Pt 1): L236-44
76. Nogee LM, de Mello DE, Dehner LP, et al. Brief report: deficiency of pulmonary surfactant protein B in congenital alveolar proteinosis. N Engl J Med 1993; 328: 406-10
77. Cole FS, Hamvas A, Nogee LM. Genetic disorders of neonatal respiratory function. Pediatr Res 2001 Aug; 50 (2): 157-62
78. Beers MF, Shuman H, Liley HG, et al. Surfactant protein B in human fetal lung: developmental and glucocorticoid regulation. Pediatr Res 1995 Nov; 38 (5): 668-75
79. Nogee LM, Dunbar III AE, Wert SE, et al. A mutation in the surfactant protein C gene associated with familial interstitial lung disease. N Engl J Med 2001 Feb 22; 344 (8): 573-9
80. Bruno MD, Bohinski RJ, Huelsman KM, et al. Lung cell-specific expression of the murine surfactant protein A (SP-A) gene is mediated by interactions between the SP-A promoter and thyroid transcription factor-1. J Biol Chem 1995 Mar 24; 270 (12): 6531-6
81. Zhou L, Lim L, Costa RH, et al. Thyroid transcription factor-1, hepatocyte nuclear factor-3beta, surfactant protein B, C, and Clara cell secretory protein in developing mouse lung. J Histochem Cytochem 1996 Oct; 44 (10): 1183-93
82. Losada A, Tovar JA, Xia HM, et al. Down-regulation of thyroid transcription factor-1 gene expression in fetal lung hypoplasia is restored by glococorticoids. Endocrinology 2000 Jun; 141 (6): 2166-73
83. Dulkerian SJ, Gonzales LW, Ning Y, et al. Regulation of surfactant protein D in human fetal lung. Am J Respir Cell Mol Biol 1996 Dec; 15 (6): 781-6
84. Rust K, Bingle L, Mariencheck W, et al. Characterization of the human surfactant protein D promoter: transcriptional regulation of SP-D gene expression by glucocorticoids. Am J Respir Cell Mol Biol 1996 Feb; 14 (2): 121-30
85. Wang JY, Yeh TF, Lin YC, et al. Measurement of pulmonary status and surfactant protein levels during dexamethasone treatment of neonatal respiratory distress syndrome. Thorax 1996 Sep; 51 (9): 907-13
86. Matalon S, O'Brodovich H. Sodium channels in alveolar epithelial cells: molecular characterization, biophysical properties, and physiological significance. Annu Rev Physiol 1999; 61: 627-61
87. O'Brodovich H. Fetal lung liquid secretion: insights using the tools of inhibitors and genetic knock-out experiments. Am J Respir Cell Mol Biol 2001 Jul; 25 (1): 8-10
88. O'Brodovich HM. Immature epithelial Na+ channel expression is one of the pathogenetic mechanisms leading to human neonatal respiratory distress syndrome. Proc Assoc Am Physicians 1996 Sep; 108 (5): 345-55
89. Hummler E, Barker P, Gatzy J, et al. Early death due to defective neonatal lung liquid clearance in alpha-ENaC-deficient mice. Nat Genet 1996 Mar; 12 (3): 325-8
90. O'Brodovich H, Canessa C, Ueda J, et al. Expression of the epithelial Na+ channel in the developing rat lung. Am J Physiol 1993 Aug; 265 (2 Pt 1): C491-6
91. Watanabe S, Matsushita K, Stokes JB, et al. Developmental regulation of epithelial sodium channel subunit mRNA expression in rat colon and lung. Am J Physiol 1998 Dec; 275 (6 Pt 1): G1227-35
92. Watanabe S, Matsushita K, McCray Jr PB, et al. Developmental expression of the epithelial Na+ channel in kidney and uroepithelia. Am J Physiol 1999 Feb; 276 (2 Pt 2): F304-14
93. Tchepichev S, Ueda J, Canessa C, et al. Lung epithelial Na channel subunits are differentially regulated during development and by steroids. Am J Physiol 1995 Sep; 269 (3 Pt 1): C805-12
94. Lazrak A, Samanta A, Venetsanou K, et al. Modification of biophysical properties of lung epithelial Na(+) channels by dexamethasone. Am J Physiol Cell Physiol 2000 Sep; 279 (3): C762-70
95. Nakamura K, Stokes JB, McCray Jr PB. Endogenous and exogenous glucocorticoid regulation of ENaC mRNA expression in developing kidney and lung. Am J Physiol Cell Physiol 2002 Sep; 283 (3): C762-72
96. Chow YH, Wang Y, Plumb J, et al. Hormonal regulation and genomic organization of the human amiloride-sensitive epithelia] sodium channel alpha subunit gene. Pediatr Res 1999 Aug; 46 (2): 208-14
97. Bremner HR, Freywald T, O'Brodovich HM, et al. Promoter analysis of the gene encoding the beta-subunit of the rat amiloride-sensitive epithelial sodium channel. Am J Physiol Lung Cell Mol Physiol 2002 Jan; 282 (1): L124-34
98. Thomas CP, Auerbach SD, Zhang C, et al. The structure of the rat amiloride-sensitive epithelial sodium channel gamma subunit gene and functional analysis of its promoter. Gene 1999 Mar 4; 228 (1-2): 111-22
99. Derfoul A, Robertson NM, Lingrel JB, et al. Regulation of the human Na/K-ATPase beta1 gene promoter by mineralocorticoid and glucocorticoid receptors. J Biol Chem 1998 Aug 14; 273 (33): 20702-11
100. O'Brodovich H, Staub O, Rossier BC, et al. Ontogeny of alpha 1- and beta 1-isoforms of Na(+)-K(+)-ATPase in fetal distal rat lung epithelium. Am J Physiol 1993 May; 264 (5 Pt 1): C1137-43
101. Chalaka S, Ingbar DH, Sharma R, et al. Na(+)-K(+)-ATPase gene regulation by glucocorticoids in a fetal lung epithelial cell line. Am J Physiol 1999 Jul; 277 (1 Pt 1): L197-203
102. Thibeault DW, Mabry S, Rezaiekhaligh M. Neonatal pulmonary oxygen toxicity in the rat and lung changes with aging. Pediatr Pulmonol 1990; 9 (2): 96-108
103. Holm BA, Notter RH, Siegle J, et al. Pulmonary physiological and surfactant changes during injury and recovery from hyperoxia. J Appl Physiol 1985 Nov; 59 (5): 1402-9
104. Moison RM, Palinckx JJ, Roest M, et al. Induction of lipid peroxidation of pulmonary surfactant by plasma of preterm babies. Lancet 1993 Jan 9; 341 (8837): 79-82
105. Frank L, Sosenko IR. Prenatal development of lung antioxidant enzymes in four species. J Pediatr 1987 Jan; 110 (1): 106-10
106. Gerdin E, Tyden O, Eriksson UJ. The development of antioxidant enzymatic defence in the perinatal rat lung: activities of superoxide dismutase, glutathione peroxidase, and catalase. Pediatr Res 1985 Jul; 19 (7): 687-91
107. Asikainen TM, Raivio KO, Saksela M, et al. Expression and developmental profile of antioxidant enzymes in human lung and liver. Am J Respir Cell Mol Biol 1998 Dec; 19 (6): 942-9
108. Frank L. Prenatal dexamethasone treatment improves survival of newborn rats during prolonged high O2 exposure. Pediatr Res 1992 Aug; 32 (2): 215-21
109. Chen Y, Martinez MA, Frank L. Prenatal dexamethasone administration to premature rats exposed to prolonged hyperoxia: a new rat model of pulmonary fibrosis (bronchopulmonary dysplasia). J Pediatr 1997 Mar; 130 (3): 409-16
110. Frank L, Lewis PL, Sosenko IR. Dexamethasone stimulation of fetal rat lung antioxidant enzyme activity in parallel with surfactant stimulation. Pediatrics 1985 Mar; 75 (3): 569-74
111. Walther FJ, David-Cu R, Mehta EI, et al. Higher lung antioxidant enzyme activity persists after single dose of corticosteroids in preterm lambs. Am J Physiol 1996 Aug; 271 (2 Pt 1): L187-91
112. Walther FJ, Jobe AH, Ikegami M. Repetitive prenatal glucocorticoid therapy reduces oxidative stress in the lungs of preterm lambs. J Appl Physiol 1998 Jul; 85 (1): 273-8
113. Horbar JD, Badger GJ, Carpenter JH, et al. Trends in mortality and morbidity for very low birth weight infants, 1991-1999. Pediatrics 2002 Jul; 110 (1 Pt 1): 143-51
114. Yeh TF, Lin YJ, Huang CC, et al. Early dexamethasone therapy in preterm infants: a follow-up study [online]. Pediatrics 1998; 101: e7
115. Grier DG, Halliday HL. Corticosteroids in the prevention and management of bronchopulmonary dysplasia. Semin Neonatol 2003 Feb; 8 (1): 83-91
116. Uno H, Lohmiller L, Thieme C, et al. Brain damage induced by prenatal exposure to dexamethasone in fetal rhesus macaques: I. Hippocampus. Brain Res Dev Brain Res 1990 May 1; 53 (2): 157-67
117. Edwards HE, Burnham WM. The impact of corticosteroids on the developing animal. Pediatr Res 2001 Oct; 50 (4): 433-40
118. Tsubota S, Adachi N, Chen J, et al. Dexamethasone changes brain monoamine metabolism and aggravates ischemic neuronal damage in rats. Anesthesiology 1999 Feb; 90 (2): 515-23
119. Matthews SG. Antenatal glucocorticoids and programming of the developing CNS. Pediatr Res 2000 Mar; 47 (3): 291-300
120. Jobe AH. Glucocorticoids in perinatal medicine: misguided rockets? J Pediatr 2000;137:1-3